This report provides a global overview of the monkeypox epidemiological situation as reported to WHO as of August 02 2022. The report focuses on laboratory confirmed cases1 as defined by the WHO’s working case definition published in the Surveillance, case investigation and contact tracing for monkeypox interim guidance. Note that countries may use their own case definitions separate from those outlined in the above document. This report should be considered in the context of other WHO information products associated with the 2022 monkeypox outbreak, and monkeypox in general:
The biweekly Situation Report provides a comprehensive update of the monkeypox situation and response activities across a variety of domains such as epidemiology, clinical management and communications, replacing the previous Disease Outbreak News format;
The Emergency Dashboard provides the latest daily data on total cases and deaths of monkeypox, as well as other events and emergencies to which WHO is responding;
This global epidemiological report provides in-depth epidemiological information about the monkeypox situation, based primarily on case report forms provided by Member States to WHO under Article 6 of the International Health Regulations (IHR 2005).
Links to these products can be see in more detail at the end of the report.
Since 1 January 2022, cases of monkeypox have been reported to WHO from 83 Member States across all 6 WHO regions. As of August 02 2022 at 17h CEST, a total of 23,351 laboratory confirmed cases and 122 probable cases, including 8 deaths, have been reported to WHO. Since 13 May 2022, a high proportion of these cases have been reported from countries without previously documented monkeypox transmission. This is the first time that cases and sustained chains of transmission have been reported in countries without direct or immediate epidemiological links to areas of West or Central Africa.
With the exception of countries2 areas of West and Central Africa, the ongoing outbreak of monkeypox continues to primarily affect men who have sex with men (MSM) who have reported recent sex with one or multiple partners. At present there is no signal suggesting sustained transmission beyond these networks.
Confirmation of one case of monkeypox, in a country, is considered an outbreak. The unexpected appearance of monkeypox in several regions in the initial absence of epidemiological links to areas in West and Central Africa, suggests that there may have been undetected transmission for some time.
WHO assesses the global risk as Moderate. Regionally, WHO assesses the risk in the European Region as High and as Moderate in the African Region, Region of the Americas, Eastern Mediterranean Region and the South-East Asia Region. The risk in the Western Pacific Region is assessed as Low-Moderate. The IHR Emergency Committee on the multi-country outbreak of monkeypox held its second meeting on 21 July 2022. Having considered the views of committee members and advisors as well as other factors in line with the International Health Regulations (2005), the WHO Director-General declared this outbreak a public health emergency of international concern and issued temporary recommendations in relation to the outbreak.
For the WHO European region, both confirmed and probable cases are included within confirmed case counts and detailed case data.
Throughout this document, any use of the word country should be considered shorthand for a country, area, or territory
All references to Kosovo should be understood to be in the context of the United Nations Security Council resolution 1244 (1999).
The number of weekly1 reported new cases globally has increased by 18.7% in week 30 (25 Jul - 31 Jul) (n = 5,206 cases) compared to week 29 (18 Jul - 24 Jul) (n = 4,387 cases). The majority of cases reported in the past 4 weeks were notified from the European Region (59.7%) and the Region of the Americas (38.5%).
The 10 most affected countries globally are: United States of America (n = 5,175), Spain (n = 4,298), Germany (n = 2,677), The United Kingdom (n = 2,546), France (n = 1,955), Brazil (n = 1,369), Netherlands (n = 879), Canada (n = 803), Portugal (n = 633), and Italy (n = 479). Together, these countries account for 89.1% of the cases reported globally.
In the past 7 days, 20 countries reported an increase in the weekly number of cases, with the highest increase reported in United States of America. 15 countries have reported no new cases in the past 21 days.
In the past 7 days, 5 countries reported their first case. countries which reported their first case in the past 7 days are: Philippines (29 July), Montenegro (31 July), Uruguay (31 July), Liberia (01 August), Sudan (01 August).
Global data are data collected by public sources. These data are largely aggregated cases that have been reported from open and official country sources. The below epidemic curve shows the aggregated number of cases by week according to the date of case reporting.
Epidemic curve shown for cases reported up to 01 Aug 2022 to avoid showing incomplete weeks of data.

Epidemic curve shown for cases reported up to 01 Aug 2022 to avoid showing incomplete weeks of data. Note different y-axis scales.


| Total Monkeypox cases, by WHO region | |||
|---|---|---|---|
| From 1 Jan 2022. Data as of 02 Aug 2022 | |||
| Total Confirmed Cases | Total Probable Cases | Total Deaths | |
| European Region | 15,058 | 0 | 2 |
| Region of the Americas | 7,843 | 122 | 0 |
| African Region | 349 | 0 | 5 |
| Western Pacific Region | 65 | 0 | 0 |
| Eastern Mediterranean Region | 28 | 0 | 0 |
| South-East Asia Region | 8 | 0 | 1 |
| Total | 23,351 | 122 | 8 |
| Total Monkeypox cases, by WHO region | |||
|---|---|---|---|
| From 1 Jan 2022. Data as of 02 Aug 2022 | |||
| Total Confirmed Cases | Total Probable Cases | Total Deaths | |
| Region of the Americas | |||
| United States of America | 5,175 | 0 | 0 |
| Brazil | 1,369 | 16 | 0 |
| Canada | 803 | 104 | 0 |
| Peru | 305 | 0 | 0 |
| Mexico | 59 | 0 | 0 |
| Chile | 55 | 1 | 0 |
| Puerto Rico | 21 | 0 | 0 |
| Argentina | 20 | 0 | 0 |
| Colombia | 16 | 0 | 0 |
| Ecuador | 5 | 0 | 0 |
| Dominican Republic | 3 | 1 | 0 |
| Costa Rica | 3 | 0 | 0 |
| Jamaica | 2 | 0 | 0 |
| Bahamas | 1 | 0 | 0 |
| Panama | 1 | 0 | 0 |
| Venezuela (Bolivarian Republic of) | 1 | 0 | 0 |
| Barbados | 1 | 0 | 0 |
| Martinique | 1 | 0 | 0 |
| Bermuda | 1 | 0 | 0 |
| Uruguay | 1 | 0 | 0 |
| European Region | |||
| Spain | 4,298 | 0 | 2 |
| Germany | 2,677 | 0 | 0 |
| The United Kingdom | 2,546 | 0 | 0 |
| France | 1,955 | 0 | 0 |
| Netherlands | 879 | 0 | 0 |
| Portugal | 633 | 0 | 0 |
| Italy | 479 | 0 | 0 |
| Belgium | 393 | 0 | 0 |
| Switzerland | 272 | 0 | 0 |
| Israel | 146 | 0 | 0 |
| Austria | 124 | 0 | 0 |
| Denmark | 99 | 0 | 0 |
| Sweden | 88 | 0 | 0 |
| Ireland | 85 | 0 | 0 |
| Poland | 59 | 0 | 0 |
| Norway | 53 | 0 | 0 |
| Hungary | 39 | 0 | 0 |
| Slovenia | 35 | 0 | 0 |
| Greece | 32 | 0 | 0 |
| Luxembourg | 28 | 0 | 0 |
| Romania | 21 | 0 | 0 |
| Czechia | 19 | 0 | 0 |
| Finland | 17 | 0 | 0 |
| Malta | 17 | 0 | 0 |
| Croatia | 12 | 0 | 0 |
| Iceland | 10 | 0 | 0 |
| Serbia | 10 | 0 | 0 |
| Estonia | 6 | 0 | 0 |
| Slovakia | 6 | 0 | 0 |
| Gibraltar | 5 | 0 | 0 |
| Bulgaria | 4 | 0 | 0 |
| Andorra | 3 | 0 | 0 |
| Latvia | 3 | 0 | 0 |
| Bosnia and Herzegovina | 1 | 0 | 0 |
| Georgia | 1 | 0 | 0 |
| Montenegro | 1 | 0 | 0 |
| Russian Federation | 1 | 0 | 0 |
| Türkiye | 1 | 0 | 0 |
| African Region | |||
| Democratic Republic of the Congo | 163 | 0 | 0 |
| Nigeria | 133 | 0 | 3 |
| Ghana | 34 | 0 | 0 |
| Cameroon | 7 | 0 | 0 |
| Benin | 3 | 0 | 0 |
| Central African Republic | 3 | 0 | 2 |
| South Africa | 3 | 0 | 0 |
| Congo | 2 | 0 | 0 |
| Liberia | 1 | 0 | 0 |
| Western Pacific Region | |||
| Australia | 45 | 0 | 0 |
| Singapore | 11 | 0 | 0 |
| New Zealand | 2 | 0 | 0 |
| China | 2 | 0 | 0 |
| Japan | 2 | 0 | 0 |
| Republic of Korea | 1 | 0 | 0 |
| New Caledonia | 1 | 0 | 0 |
| Philippines | 1 | 0 | 0 |
| Eastern Mediterranean Region | |||
| United Arab Emirates | 16 | 0 | 0 |
| Lebanon | 4 | 0 | 0 |
| Saudi Arabia | 4 | 0 | 0 |
| Qatar | 2 | 0 | 0 |
| Morocco | 1 | 0 | 0 |
| Sudan | 1 | 0 | 0 |
| South-East Asia Region | |||
| India | 6 | 0 | 1 |
| Thailand | 2 | 0 | 0 |
| - | |||
| Total | 23,351 | 122 | 8 |
| Summary of Monkeypox cases | ||||||
|---|---|---|---|---|---|---|
| As of 02 Aug 2022 | ||||||
| Total Cases | Total cases per 1M inhabitants | Cases in past 7 days | 7-day % change in cases | Days since last report | Date of first reported case | |
| African Region | ||||||
| Democratic Republic of the Congo | 163 | 2 | 0 | 0% | 1 | 13 Jun 2022 |
| Nigeria | 133 | 1 | 16 | 0% | 1 | 02 Jan 2022 |
| Ghana | 34 | 1 | 4 | −64% | 1 | 13 Jun 2022 |
| Cameroon | 7 | 0 | 0 | 0% | 1 | 13 Jun 2022 |
| Benin | 3 | 0 | 0 | 0% | 1 | 15 Jun 2022 |
| Central African Republic | 3 | 1 | 0 | 0% | 1 | 13 Feb 2022 |
| South Africa | 3 | 0 | 0 | 0% | 1 | 23 Jun 2022 |
| Congo | 2 | 0 | 0 | 0% | 1 | 21 May 2022 |
| Liberia | 1 | 0 | 1 | 100% | 1 | 01 Aug 2022 |
| Summary of Monkeypox cases | ||||||
|---|---|---|---|---|---|---|
| As of 02 Aug 2022 | ||||||
| Total Cases | Total cases per 1M inhabitants | Cases in past 7 days | 7-day % change in cases | Days since last report | Date of first reported case | |
| Region of the Americas | ||||||
| United States of America | 5,175 | 16 | 2,294 | 110% | 0 | 03 Jun 2022 |
| Brazil | 1,369 | 6 | 673 | 120% | 0 | 10 Jun 2022 |
| Canada | 803 | 21 | 122 | −14% | 3 | 03 Jun 2022 |
| Peru | 305 | 9 | 102 | −18% | 0 | 28 Jun 2022 |
| Mexico | 59 | 0 | 0 | −100% | 9 | 03 Jun 2022 |
| Chile | 55 | 3 | 16 | −16% | 3 | 18 Jun 2022 |
| Puerto Rico | 21 | 7 | 8 | 60% | 0 | 01 Jul 2022 |
| Argentina | 20 | 0 | 0 | −100% | 7 | 03 Jun 2022 |
| Colombia | 16 | 0 | 4 | −20% | 1 | 25 Jun 2022 |
| Ecuador | 5 | 0 | 2 | 0% | 0 | 14 Jun 2022 |
| Costa Rica | 3 | 1 | 2 | 100% | 5 | 21 Jul 2022 |
| Dominican Republic | 3 | 0 | 0 | −100% | 11 | 06 Jul 2022 |
| Jamaica | 2 | 1 | 0 | −100% | 7 | 08 Jul 2022 |
| Bahamas | 1 | 2 | 0 | 0% | 36 | 27 Jun 2022 |
| Barbados | 1 | 4 | 0 | 0% | 14 | 19 Jul 2022 |
| Bermuda | 1 | 16 | 0 | −100% | 10 | 23 Jul 2022 |
| Martinique | 1 | 3 | 0 | −100% | 13 | 20 Jul 2022 |
| Panama | 1 | 0 | 0 | 0% | 27 | 06 Jul 2022 |
| Uruguay | 1 | 0 | 1 | 100% | 2 | 31 Jul 2022 |
| Venezuela (Bolivarian Republic of) | 1 | 0 | 0 | 0% | 48 | 14 Jun 2022 |
| Summary of Monkeypox cases | ||||||
|---|---|---|---|---|---|---|
| As of 02 Aug 2022 | ||||||
| Total Cases | Total cases per 1M inhabitants | Cases in past 7 days | 7-day % change in cases | Days since last report | Date of first reported case | |
| Eastern Mediterranean Region | ||||||
| United Arab Emirates | 16 | 2 | 0 | −100% | 9 | 24 May 2022 |
| Lebanon | 4 | 1 | 0 | −100% | 12 | 20 Jun 2022 |
| Saudi Arabia | 4 | 0 | 2 | 100% | 2 | 14 Jul 2022 |
| Qatar | 2 | 1 | 0 | −100% | 9 | 21 Jul 2022 |
| Morocco | 1 | 0 | 0 | 0% | 49 | 02 Jun 2022 |
| Sudan | 1 | 0 | 1 | 100% | 1 | 01 Aug 2022 |
| Summary of Monkeypox cases | ||||||
|---|---|---|---|---|---|---|
| As of 02 Aug 2022 | ||||||
| Total Cases | Total cases per 1M inhabitants | Cases in past 7 days | 7-day % change in cases | Days since last report | Date of first reported case | |
| European Region | ||||||
| Spain | 4,298 | 91 | 702 | −8% | 1 | 18 May 2022 |
| Germany | 2,677 | 32 | 267 | −29% | 1 | 20 May 2022 |
| The United Kingdom | 2,546 | 38 | 338 | 260% | 1 | 07 May 2022 |
| France | 1,955 | 30 | 388 | −41% | 1 | 19 May 2022 |
| Netherlands | 879 | 50 | 61 | −62% | 1 | 22 May 2022 |
| Portugal | 633 | 62 | 45 | −38% | 1 | 17 May 2022 |
| Italy | 479 | 8 | 53 | 2% | 1 | 19 May 2022 |
| Belgium | 393 | 34 | 0 | −100% | 1 | 19 May 2022 |
| Switzerland | 272 | 31 | 38 | 46% | 1 | 21 May 2022 |
| Israel | 146 | 17 | 25 | 32% | 1 | 21 May 2022 |
| Austria | 124 | 14 | 13 | −43% | 1 | 23 May 2022 |
| Denmark | 99 | 17 | 39 | 130% | 1 | 23 May 2022 |
| Sweden | 88 | 8 | 7 | −30% | 1 | 18 May 2022 |
| Ireland | 85 | 17 | 0 | −100% | 1 | 16 May 2022 |
| Poland | 59 | 2 | 6 | −54% | 1 | 13 Jun 2022 |
| Norway | 53 | 10 | 4 | −20% | 1 | 31 May 2022 |
| Hungary | 39 | 4 | 2 | −60% | 1 | 31 May 2022 |
| Slovenia | 35 | 17 | 2 | −71% | 1 | 24 May 2022 |
| Greece | 32 | 3 | 3 | −73% | 1 | 09 Jun 2022 |
| Luxembourg | 28 | 45 | 9 | 0% | 1 | 16 Jun 2022 |
| Romania | 21 | 1 | 1 | 0% | 1 | 14 Jun 2022 |
| Czechia | 19 | 2 | 3 | 50% | 1 | 24 May 2022 |
| Finland | 17 | 3 | 0 | −100% | 1 | 20 May 2022 |
| Malta | 17 | 33 | 0 | 0% | 1 | 30 May 2022 |
| Croatia | 12 | 3 | 2 | −50% | 1 | 24 Jun 2022 |
| Iceland | 10 | 28 | 1 | −50% | 1 | 09 Jun 2022 |
| Serbia | 10 | 1 | 0 | −100% | 1 | 17 Jun 2022 |
| Estonia | 6 | 4 | 2 | 100% | 1 | 28 Jun 2022 |
| Slovakia | 6 | 1 | 3 | 200% | 1 | 07 Jul 2022 |
| Gibraltar | 5 | 148 | 0 | 0% | 1 | 02 Jun 2022 |
| Bulgaria | 4 | 1 | 0 | −100% | 1 | 23 Jun 2022 |
| Andorra | 3 | 39 | 0 | −100% | 1 | 25 Jul 2022 |
| Latvia | 3 | 2 | 0 | −100% | 1 | 03 Jun 2022 |
| Bosnia and Herzegovina | 1 | 0 | 0 | 0% | 1 | 14 Jul 2022 |
| Georgia | 1 | 0 | 0 | 0% | 1 | 15 Jun 2022 |
| Montenegro | 1 | 2 | 1 | 100% | 2 | 31 Jul 2022 |
| Russian Federation | 1 | 0 | 0 | 0% | 1 | 12 Jul 2022 |
| Türkiye | 1 | 0 | 0 | 0% | 1 | 30 Jun 2022 |
| Summary of Monkeypox cases | ||||||
|---|---|---|---|---|---|---|
| As of 02 Aug 2022 | ||||||
| Total Cases | Total cases per 1M inhabitants | Cases in past 7 days | 7-day % change in cases | Days since last report | Date of first reported case | |
| South-East Asia Region | ||||||
| India | 6 | 0 | 0 | −100% | 8 | 14 Jul 2022 |
| Thailand | 2 | 0 | 1 | 0% | 5 | 21 Jul 2022 |
| Summary of Monkeypox cases | ||||||
|---|---|---|---|---|---|---|
| As of 02 Aug 2022 | ||||||
| Total Cases | Total cases per 1M inhabitants | Cases in past 7 days | 7-day % change in cases | Days since last report | Date of first reported case | |
| Western Pacific Region | ||||||
| Australia | 45 | 2 | 1 | −67% | 5 | 20 May 2022 |
| Singapore | 11 | 2 | 1 | −75% | 6 | 21 Jun 2022 |
| China | 2 | 0 | 0 | 0% | 21 | 24 Jun 2022 |
| Japan | 2 | 0 | 1 | 0% | 6 | 25 Jul 2022 |
| New Zealand | 2 | 0 | 0 | 0% | 22 | 11 Jul 2022 |
| New Caledonia | 1 | 4 | 0 | 0% | 21 | 12 Jul 2022 |
| Philippines | 1 | 0 | 1 | 100% | 4 | 29 Jul 2022 |
| Republic of Korea | 1 | 0 | 0 | 0% | 41 | 22 Jun 2022 |
| Days since last reported case | ||
|---|---|---|
| As of 02 Aug 2022 | ||
| Last Reported Case | Days Elapsed | |
| African Region | ||
| Congo | 21 May 2022 | 73 |
| Benin | 15 Jun 2022 | 48 |
| Central African Republic | 3 Jul 2022 | 30 |
| Cameroon | 12 Jul 2022 | 21 |
| Eastern Mediterranean Region | ||
| Morocco | 2 Jun 2022 | 61 |
| European Region | ||
| Georgia | 15 Jun 2022 | 48 |
| Türkiye | 30 Jun 2022 | 33 |
| Russian Federation | 12 Jul 2022 | 21 |
| Region of the Americas | ||
| Venezuela (Bolivarian Republic of) | 15 Jun 2022 | 48 |
| Bahamas | 27 Jun 2022 | 36 |
| Panama | 6 Jul 2022 | 27 |
| Western Pacific Region | ||
| Republic of Korea | 22 Jun 2022 | 41 |
| New Zealand | 11 Jul 2022 | 22 |
| China | 12 Jul 2022 | 21 |
| New Caledonia | 12 Jul 2022 | 21 |
Epidemic curve shown for cases reported up to 01 Aug 2022 to avoid showing incomplete weeks of data. In general, trends should be interpretted with caution, as the majority of countries do not report cases on a daily basis.
Detailed case data are acquired via direct reporting of case based data via WHO Member States. Data from cases are reported1 according to the WHO minimum dataset under the International Health Regulations (IHR 2005) Article 6, and subsequently aggreagated and presented below. Note that completeness of records is variable, meaning denominators for each output may be different from one another. All of the following is derived from the detailed case data, and as a result, overall numbers may not be reflective of figures shown with aggregate case numbers. All detailed cases shown are confirmed cases, where the reporting date occured after 01 January 2022.
The detailed case dataset was last updated on August 02 2022. As of this date, the total number of detailed confirmed cases reported is 19,335, representing 86.7% of all aggregated cases reported.
The table below indicate the reporting coverage between reported aggregated confirmed cases and detailed confirmed cases by countries and per region.
Note that for all tables below, in order to best align modes of reporting, total confirmed cases are shown as of:
The most recent Friday (29 July) for data in the Region of the Americas.
The most recent Tuesday (02 August) for data in the European Region.
Total cases shown fully as of 02 August are shown in the global trends section.
| Monkeypox reporting completeness | |||
|---|---|---|---|
| As of 01 Aug 20221 | |||
| Total Confirmed Cases | Total Detailed Confirmed Cases2 | % Detailed Cases reported | |
| European Region | 15,058 | 15,624 | 103.8% |
| Region of the Americas | 6,785 | 3,499 | 51.6% |
| African Region | 349 | 173 | 49.6% |
| Western Pacific Region | 65 | 13 | 20.0% |
| Eastern Mediterranean Region | 28 | 24 | 85.7% |
| South-East Asia Region | 8 | 2 | 25.0% |
| 1 Total confirmed cases shown as of date of last detailed case report for the WHO Region of the Americas and WHO European Region. | |||
| 2 Note that in rare cases total detailed cases may exceed total confirmed cases due to ongoing data cleaning issues | |||
Trends in cases are shown for all submitted detailed cases. These are shown by:
Note that reporting of detailed cases is subject to some delay. The epidemic curves shown are not right censored, and therefore trends in the most recent 1-3 weeks should be interpreted with caution. It should be additionally noted that date of report does not reflect the date of reporting to WHO, but rather reporting to national or regional authorities.
Delay between date of onset and date of report were calculated for all countries where reporting quality passed minimum quality checks. Delays were only shown when the time between onset and reporting was between -5 and 40 days.
Median delay between onset and reporting was 7 days
The interquartile range between onset and reporting was 4-10 days.





Note that reported sexual orientation does not necessarily reflect who the case has had recent sexual history with nor does it imply sexual activity.


The following outputs reflect various demographic characteristics in confirmed monkeypox cases. Note that these data are only derived from detailed case data, and as a result, total numbers of cases and deaths may differ from those reported via aggregate case data where reporting is not fully aligned.
As shown below, and stated previously, the ongoing outbreak is largely developing in MSM (Men who have Sex with Men; defined as homosexual or bisexual males in reporting forms) networks. In the following analyses, we have re-coded men reported as bisexual as MSM. Note that reported sexual orientation does not necessarily reflect who the case has had recent sexual history with nor does it imply sexual activity. Generally, severity has been low, with few reported hospitalisations and deaths:
98.8% (16515/16719) of cases with available data are male, the median age is 37 years (IQR: 31 - 43).
Males between 18-44 years old continue to be disproportionately affected by this outbreak as they account for 76.7% of cases.
Of the 16,969 cases where age was available, there were 96 (0.6%) cases reported aged 0-17, out of which 25 (0.1%) were aged 0-4.
Among cases with known data on sexual orientation, 97.5% (7327/7513) identified as MSM. Of those identified as MSM, 73 / 7327 (1.0%) were identified as bisexual men.
Among those with known HIV status 37.6% (2,979/7,924) were HIV-positive. Note that information on HIV status is not available for the majority of cases, and for those for which it is available, it is likely to be skewed towards those reporting positive HIV results.
339 cases were reported to be health workers. However, most were infected in the community and further investigation is ongoing to determine whether the remaining infection was due to occupational exposure.
Of all reported types of transmission, a sexual encounter was reported most commonly, with 4,808 of 5,255 (91.5%) of all reported transmission events.
Of all settings in which cases were likely exposed, the most common was in large event with sexual contacts, with 277 of 1,277 (21.7%) of all likely exposure categories.
Note that the proportions shown below should be interpreted with caution. When considering some variables, it is more likely that a yes response will be obtained when compared to a no response after consideration of true proportions of these factors. This is most likely to be true for variables where reported answers can only be yes or no, such as HIV status, health worker status, travel history, hospitalisation, ICU, and death.
| Case profiles | |||
|---|---|---|---|
| As of August 02 2022 | |||
| Reported values1 | Unknown or Missing Value | ||
| Yes | No | ||
| MSM | 7326 (97.5%) | 186 (2.5%) | 11812 |
| HIV-Positive | 2979 (37.6%) | 4944 (62.4%) | 11401 |
| Health worker | 339 (13.5%) | 2169 (86.5%) | 16816 |
| Travel History | 784 (35.3%) | 1437 (64.7%) | 17103 |
| Sexual Transmission | 4807 (91.5%) | 447 (8.5%) | 14070 |
| Hospitalised2 | 559 (7.1%) | 7297 (92.9%) | 11468 |
| ICU | 3 (0.1%) | 3713 (99.9%) | 15608 |
| Died | 2 (0.0%) | 10650 (100.0%) | 8672 |
| 1 Note given true proportions of variables, yes reporting may be common than no reporting | |||
| 2 May be hospitalised for isolation or medical treatment | |||

Transmission data were available for 5,255/19,335 (27.2%) of cases.
When considering transmission, note that dissociation between transmission via skin-to-skin contact during sex and transmission via bodily fluids cannot be disentangled. While skin-to-skin contact with lesions remains an important transmission route, monkeypox virus has been isolated from semen samples and rectal swabs from confirmed cases.

Exposure setting data were available for 1,212/19,335 (6.3%) of cases.
Note that multiple exposure settings can be attributed to a single case. Here, differentiation here between party settings and large events is determined by size of the event, although there is no formal size threshold to distinguish the two.

The following outputs apply to only those individuals where sexual orientation has been reported, but it is not MSM. Non-MSM categories of sexual orientation that are reportable are:
As stated above, MSM in this case refers to those who have a reported sexual orientation of MSM, and men reported as bisexual. As above, note that reported sexual orientation does not necessarily reflect persons who the case has had recent sexual history with nor does it imply sexual activity. Up until this point in time, the 2022 multi-country Monkeypox outbreak has been overwhelmingly concentrated in MSM networks. For this reason, understanding events in which non-MSM individuals have acquired monkeypox is important to monitor potential of sustained spillover into the general population.
65.2% (120/184) of cases with available data are male; the median age is 34.5 years (IQR: 28-44).
Males between 18-44 years old account for 49.5% of cases.
Among those with known HIV status 7.1% (11/156) were HIV-positive. Note that information on HIV status is not available for the majority of cases, and for those for which it is available, it is likely to be skewed towards those reporting positive HIV results.
2 cases were reported to be health workers. However, most were infected in the community and further investigation is ongoing to determine whether the remaining infection was due to occupational exposure.
Of all reported types of transmission, sexual encounter was reported most commonly, with 69 of 94 (73.4%) of all reported transmission events.
Of all settings in which cases were likely exposed, the most common was in households, with 10 of 44 (22.7%) of all likely exposure categories.
Note that the proportions shown below should be interpreted with caution. When considering some variables, it is more likely that a yes response will be obtained when compared to a no response after consideration of true proportions of these factors. This is most likely to be true for variables where reported answers can only be yes or no, such as HIV status, health worker status, travel history, hospitalisation, ICU, and death.
| Case profiles (Non-MSM) | |||
|---|---|---|---|
| As of August 02 2022 | |||
| Reported values1 | Unknown or Missing Value | ||
| Yes | No | ||
| MSM | 0 | 186 (100.0%) | 0 |
| HIV-Positive | 11 (7.1%) | 145 (92.9%) | 30 |
| Health worker | 2 (1.9%) | 106 (98.1%) | 78 |
| Travel History | 24 (34.8%) | 45 (65.2%) | 117 |
| Sexual Transmission | 69 (73.4%) | 25 (26.6%) | 92 |
| Hospitalised2 | 34 (19.2%) | 143 (80.8%) | 9 |
| ICU | 0 | 89 (100.0%) | 97 |
| Died | 0 | 180 (100.0%) | 6 |
| 1 Note given true proportions of variables, yes reporting may be common than no reporting | |||
| 2 May be hospitalised for isolation or medical treatment | |||

Transmission data were available for 94/186 (50.5%) of cases.
When considering transmission, note that dissociation between transmission via skin-to-skin contact during sex and transmission via bodily fluids cannot be disentangled. While skin-to-skin contact with lesions remains an important transmission route, monkeypox virus has been isolated from semen samples and rectal swabs from confirmed cases.

Exposure setting data were available for 43/186 (23.1%) of non-MSM cases.
Note that multiple exposure settings can be attributed to a single case. Here, differentiation here between party settings and large events is determined by size of the event, although there is no formal size threshold to distinguish the two.

Although most cases in current outbreaks have presented with mild disease symptoms, monkeypox virus (MPXV) may cause severe disease in certain population groups (young children, pregnant women, immunosuppressed persons)
Among the cases who reported at least one symptom, the most common symptom is any rash and is reported in 83% of cases with at least one reported symptom. Note that identifying true denominators for symptomatology is difficult due to a general lack of negative reporting and symptom definitions that may vary between countries’ reporting systems.
A bar chart and table showing symptoms is shown below. Here any rash refers to one or more rash symptoms (systemic, oral, genital, or unknown location), and any lymphadenopathy refers to either general or local lymphadenopathy.

| Summary of symptoms | |
|---|---|
| As of August 02 2022 | |
| Number | |
| Any rash | 10688 (83.4%) |
| Systemic rash | 8293 (64.7%) |
| Fever | 5568 (43.5%) |
| Genital rash | 4661 (36.4%) |
| Any lymphadenopathy | 3735 (29.2%) |
| Lymphadenopathy | 3664 (28.6%) |
| Local lymphadenopathy | 3084 (24.1%) |
| Fatigue | 2575 (20.1%) |
| Headache | 2429 (19.0%) |
| Muscle ache | 2354 (18.4%) |
| Asymptomatic | 1759 (13.7%) |
| Oral rash | 1197 (9.3%) |
| Cough | 175 (1.4%) |
| Vomiting | 73 (0.6%) |
| Chills | 0 |
| Conjunctivitis | 0 |
| Sore throat | 0 |
| Other | 0 |
Since 1970, human cases of monkeypox have been reported in 9 countries in the WHO African region: Cameroon, Central African Republic, Congo, Côte d’Ivoire, Democratic Republic of the Congo, Gabon, Liberia, Nigeria, and Sierra Leone. The true burden of monkeypox in these countries is not known. This section specifically focuses on those countries in the African region with a history of monkeypox, in order to highlight any differences in epidemiology between those countries and those within the ongoing 2022 monkeypox outbreak without a history of monkeypox. Notably, while the ongoing 2022 monkeypox outbreak has been associated with the west African clade of the monkeypox virus, historically outbreaks have been driven by that and the central African clade.
Historically, the sexual component of transmission in the countries above has been thought to contribute less to human to human transmission of monkeypox than has been observed in the ongoing global outbreak. It should also be noted that there is limited testing capacity for monkeypox in many of these countries, which has led to underascertainment of monkeypox cases.
In 2022, as of 01 Aug 2022, there have been 309 confirmed cases of monkeypox reported in these countries and 5 deaths. These represent 1% and 62% of global cases and deaths respectively. In addition, 173 (56% of all cases) detailed cases have been reported to WHO.
Of those cases with detailed data:
110 male cases (64.3%) and 61 female cases (35.7%) have been reported
The median age is 25 (IQR: 11 - 35).
Of the 168 cases where age was available, there were 65 (38.7% of total) cases reported aged 0-17, out of which 21 (12.5% of total) were aged 0-4.
There are currently no detailed cases for which transmission or exposure setting detail is available
Trends from these countries are shown below:
Epidemic curve shown for cases reported up to 01 Aug 2022 to avoid showing incomplete weeks of data.

This epidemic curve is shown for those cases with detailed case data, giving date of onset.


Users are advised to interpret all data with caution and be aware of their limitations. Case counts and their corresponding data may be retrospectively corrected as new information is collected and reported.
We gratefully acknowledge the input of national public health staff involved in surveillance activities and data submission to WHO, the European Centre for Disease Prevention and Control (ECDC) for the provision of surveillance data collected via the TESSy platform, as well as external partners who contributed additional insights and contextual information on the data.